Hideharu Okamatsu

Hideharu Okamatsu

Auto-generated profile, based on publicly available information

Hideharu Okamatsu

Division of Cardiology Saiseikai Kumamoto Hospital Kumamoto Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2019 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
HOHideharu Okamatsu
Hideharu Okamatsu
JKJunjiro Koyama
Junjiro Koyama
YSYoshirou Sakai
Yoshirou Sakai
KNKoudai Negishi
Koudai Negishi
KHKatsuhide Hayashi
Katsuhide Hayashi
KOKen Okumura
Ken Okumura

18 August 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
TSTetsuya Saito
Tetsuya Saito
HTHikaru Tsuruta
Hikaru Tsuruta
AKAkiyoshi Kajino
Akiyoshi Kajino
JIJuri Iwata
Juri Iwata
SSShingo Sakata
Shingo Sakata
TIthe OCEAN‐LAAC investigators
the OCEAN‐LAAC investigators
Background: The impact of peridevice leak (PDL) at device implantation on clinical outcomes after percutaneous left atrial appendage closure (LAAC) is unknown. This study aimed to investigate the association between PDL and clinical outcomes after LAAC. Methods: Using data from the OCEAN‐LAAC (Optimized Catheter Valvular Intervention‐Left Atrial Appendage Closure) Japanese multicenter registry, we examined 1397 patients who underwent LAAC between September 2019 and December 2022. The primary outcome was transient ischemic attack, ischemic stroke, or systemic embolism within 2 years of LAAC. Clinical outcomes were compared between patients with and without PDL at device implantation using Fine and Gray multivariable regression analyses and propensity score matching. Additional analyses were performed by categorizing PDL into 2 groups: ≤3 mm and >3 mm but ≤5 mm. Results: Of 1397 patients who underwent LAAC, 84 (6.0%) had PDL, of whom 73 (86.9%) had ≤3 mm PDL. Patients with PDL had a larger left atrium and higher CHADS2 scores than those without PDL. Multivariable analyses showed that PDL was significantly associated with a higher risk of transient ischemic attack, ischemic stroke, or systemic embolism (adjusted subdistribution hazard ratio [sHR], 4.25 [95% CI, 1.91–9.44]; P <0.001). Even PDL ≤3 mm was independently associated with an increased risk compared with no PDL (adjusted sHR, 3.53 [95% CI, 1.37–9.04]; P =0.016). Propensity score matching analyses revealed consistent findings. Conclusions: PDL was associated with a higher risk of transient ischemic attack, ischemic stroke, or systemic embolism, even PDL ≤3 mm. Therefore, it may be necessary to aim for no PDL as much as possible.

1 January 2018 in Circulation Journal
Verified
Journal Article
Open access
PDF file
HOHideharu Okamatsu
Hideharu Okamatsu
KOKen Okumura
Ken Okumura
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

18 May 2023 in Clinical Cardiology
Verified
Journal Article
Open access
HOHideharu Okamatsu
Hideharu Okamatsu
KOKen Okumura
Ken Okumura
FOFumitaka Onishi
Fumitaka Onishi
AYAkino Yoshimura
Akino Yoshimura
KNKodai Negishi
Kodai Negishi
JKJunjiro Koyama
Junjiro Koyama
Background: Limited data on the efficacy and safety of atrial fibrillation (AF) ablation using an ablation index (AI) for octogenarians is available. We aimed to compare the efficacy and safety of AI‐guided AF ablation between AF patients aged ≥80 years (Group 1) and <80 (Group 2).Hypothesis: We hypothesized that AI‐guided AF ablation could complete the procedure with comparable efficiency and safety in patients aged ≥80 years and <80.Methods: We retrospectively reviewed 2087 AF patients undergoing their first AI‐guided AF ablation in our hospital. We compared the atrial tachyarrhythmia (AT) recurrence and procedure‐related complication rate between Group 1 (n = 193) and Group 2 (n = 1894).Results: The mean age was 83.0 (interquartile range [IQR] 81.0, 84.0) years in Group 1 and 67.0 (IQR 60.0, 72.0) in Group 2. AF type was significantly different between the two groups: Of Group 1 patients, 120 (62.2%) had paroxysmal AF, 61 (31.6%) persistent AF, and 12 (6.2%) long‐standing persistent AF, while of Group 2 patients, 1016 (53.6%) paroxysmal AF, 582 (30.7%) persistent AF, and 296 (15.6%) long‐standing persistent AF (p = .001). Unadjusted AT recurrence‐free survival curves showed similar AT recurrence‐free survival between the two groups (p = .67 by log‐rank test). After the adjustment for AF type, the survival curve was similar between them (hazard ratio, 1.24; 95% CI [0.92–1.65]; p = .15, Group 1 vs. Group 2). The rate of procedure‐related complications was similar between the two groups (3.1% vs. 3.0%, respectively, p = .83).Conclusion: Catheter ablation guided by AI achieved similar AT recurrence and complication rates between elderly AF patients aged ≥80 years and patients <80 years.

18 November 2021 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
KHKatsuhide Hayashi
Katsuhide Hayashi
KOKen Okumura
Ken Okumura
HOHideharu Okamatsu
Hideharu Okamatsu
SKShozo Kaneko
Shozo Kaneko
KNKodai Negishi
Kodai Negishi
JKJunjiro Koyama
Junjiro Koyama

3 October 2023 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
HOHideharu Okamatsu
Hideharu Okamatsu
KOKen Okumura
Ken Okumura
FOFumitaka Onishi
Fumitaka Onishi
AYAkino Yoshimura
Akino Yoshimura
KNKodai Negishi
Kodai Negishi
JKJunjiro Koyama
Junjiro Koyama